2Matthew E,Patra F,Koletsi K,et a1.The diversity of definitionsof multi drug-resistant(MDR)and pan drug resistant(PDR) Acinetobacter baumannii and Pseudomonas aeruginosa[J].J Med Microbio,2006,55:1619.
3Bonomo RA,Szabo D.Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa[J].Clin Infect Dis,2006,43:49.
4Poirel L,Nordmann P.Carbapenem resistance in Acinetobacter baumannii:mechanisms and epidemiology[J].Clin Microbiol Infect,2006,12:826.
5Peleg AY,Adams J,Paterson DL.Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii[J].Antimicrob Agents Chemother,2007,51:2065.
6Betrosian AP,Frantzeskaki F,Xanthaki A,et al.High-dose ampicillinsulbactamas an alternative treatment oflate-onset VAP from multidrug-resistant Acinetobacter baumannii[J].Scand J Infect Dis,2007,39:38.
7Betrosian AP,Frantzeskaki F,Xanthaki A,et al.Efficacy and safety of high-dose ampicillin/sulbactam vs.colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associatedpneumonia[J].Infect,2008,56:432.
8Lee NY,Wang CL,Chuang YC,et al.Combination carbapenem-sulbactam therapy for critically ill patients with multidrugresistant Acinetobacter baumannii bacteremia:four case reports and an in vitro combination synergy study[J].Pharmacotherapy,2007,27:1506.
10Dalgic N,Ceylan Y,Sancar M,et al.Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin[J].Annals of Tropical Paediatrics,2009,29:2.
